TORNTPHARM On Other Exchanges
Symbol
Exchange
TORNTPHARM is not on other exchanges.

Executive Profile*

Sudhir Uttamlal Mehta

AgeTotal Calculated CompensationThis person is connected to 15 board members in 3 different organizations across 5 different industries.

See Board Relationships
6450,000,000
As of Fiscal Year 2018

Background*

Mr. Sudhir Uttamlal Mehta is Chairman Emeritus of Torrent Pharmaceuticals Ltd and Torrent Power Ltd. Mr. Mehta serves as the Chairman of Torrent Group, of which Torrent Pharmaceuticals Limited is the flagship. Mr. Mehta was an Executive Chairman of Torrent Power Limited from October 1, 2006 to March 2018. He was instrumental in the growth and progress of Torrent Pharmaceuticals Limited (TPL). He has managed strategic alliances with leading international giants from UK, ...

Read Full Background

\

Corporate Headquarters*

Torrent House
Ahmedabad, Gujarat 380009

India

Phone: 91 79 2659 9000
Fax: 91 79 2658 2100

Board Members Memberships*

Chairman
Chairman Emeritus
2009-Present
Chairman Emeritus

Education*

Unknown/Other Education
Gujarat University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation50,000,000
Total Calculated Compensation50,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
S. Sridhar Chief Executive Officer, MD, Lead of Essential Health Portfolio & Director
Pfizer Limited
34.3M
Murali Krishna Prasad Divi Chairman & MD
Divi's Laboratories Limited
402.0M
Ambati Venu MD & Executive Director
Abbott India Limited
58.6M
Chirayu Ramanbha Amin Executive Chairman & CEO
Alembic Pharmaceuticals Limited
220.0M
Compensation as of Fiscal Year 2018.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TORRENT PHARMACEUTICALS LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.